Last reviewed · How we verify
NovoMix® 30 Penfill®
NovoMix® 30 Penfill® is a Small molecule drug developed by Geropharm. It is currently in Phase 1 development. Also known as: biphasic insulin aspart 30.
At a glance
| Generic name | NovoMix® 30 Penfill® |
|---|---|
| Also known as | biphasic insulin aspart 30 |
| Sponsor | Geropharm |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects (NA)
- A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus (T2DM)
- Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NovoMix® 30 Penfill® CI brief — competitive landscape report
- NovoMix® 30 Penfill® updates RSS · CI watch RSS
- Geropharm portfolio CI
Frequently asked questions about NovoMix® 30 Penfill®
What is NovoMix® 30 Penfill®?
NovoMix® 30 Penfill® is a Small molecule drug developed by Geropharm.
Who makes NovoMix® 30 Penfill®?
NovoMix® 30 Penfill® is developed by Geropharm (see full Geropharm pipeline at /company/geropharm).
Is NovoMix® 30 Penfill® also known as anything else?
NovoMix® 30 Penfill® is also known as biphasic insulin aspart 30.
What development phase is NovoMix® 30 Penfill® in?
NovoMix® 30 Penfill® is in Phase 1.
Related
- Manufacturer: Geropharm — full pipeline
- Also known as: biphasic insulin aspart 30
- Compare: NovoMix® 30 Penfill® vs similar drugs
- Pricing: NovoMix® 30 Penfill® cost, discount & access